Search for: "Astrazeneca" Results 221 - 240 of 1,244
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Jul 2020, 6:26 am by Robert Kraft
Most of the vaccine makers to receive the contracts “are pillars of the pharmaceutical industry: AstraZeneca, Johnson & Johnson, Merck and Sanofi,” and only Moderna, which is “working with the National Institute of Allergy and Infectious Diseases, isn’t a well-known name. [read post]
5 Jul 2020, 5:43 am by Annsley Merelle Ward
  AstraZeneca, Eli Lilly, Merck Sharp & Dohme, Pfizer and GlaxoSmithKline are working with IFPMA (International Federation of Pharmaceutical Manufacturers and Associations) and the World Health Organisation as part of a global team to speed up the development of safe and effective vaccines and remedies against Covid-19. [read post]
25 May 2020, 9:31 am by Financial Times
The race for a vaccine appeared to be picking up pace this week when Moderna, a Boston-based biotech company, unveiled early positive results for its potential vaccine in a small trial—and AstraZeneca said it could have the first doses of another vaccine delivered by October if trials are successful.Read 33 remaining paragraphs | Comments [read post]
25 Apr 2020, 12:52 am by Léon Dijkman
Although the question has not been put to the Dutch Supreme Court in literal terms, two recent decisions – Resolution/AstraZeneca (2018) and Bayer/Sandoz (2016) – suggest that under Dutch patent law, "disclosed but not claimed is disclaimed" is not an absolute maxim. [read post]
12 Mar 2020, 1:48 am by Sophie Corke
In relation to AstraZeneca, Chris considered that the objection was basically that the company was insufficiently transparent – but he said it was hard to see how it could actually be considered anticompetitive. [read post]
19 Feb 2020, 4:03 pm by Doyle, Barlow & Mazard PLLC
Second, the consumer groups contend that AstraZeneca is a questionable buyer for brazikumab. [read post]
19 Feb 2020, 1:03 pm by Doyle, Barlow & Mazard PLLC
Consumer Group Concerns Regarding Rebate Walls and the Proposed Divestiture The letter expresses concerns that the proposed divestiture to AstraZeneca of Allergan’s brazikumab, a drug in development, is inadequate to address the clear anticompetitive effects of the AbbVie/Allergan merger. [read post]
18 Feb 2020, 4:00 am by Martin Kratz
Pfizer Canada ULC, 2020 FC 1, at para. 48. [12] See Free World Trust, supra, at paragraph 13; Apotex Inc v Wellcome Foundation Ltd, 2002 SCC 77 at paragraph 37, [2002] 4 SCR 153; AstraZeneca Canada Inc v Apotex Inc, 2017 SCC 36 at paragraph 39, [2017] 1 SCR 943 [13] See Free World Trust, supra, at paragraphs 33–43; applied in Seedlings Life Science Ventures, LLC v. [read post]
9 Feb 2020, 9:50 pm by Patent Docs
Rose Hughes of AstraZeneca and Caroline Peel of Clarivate Analytics will discuss the trends shaping the biosequence technology landscape and also give attendees a preview into what these trends mean for the industry at large. [read post]
6 Nov 2019, 3:18 pm by Alaric Dearment - MedCity News
The drug is also the subject of a $7 billion partnership with AstraZeneca. [read post]
27 Sep 2019, 6:00 am by Rebecca Tushnet
Harvard Law SchoolOpening KeynoteYochai Benkler, Harvard UniversityHow do we understand what we do in our field against the background of profoundly increased inequality and stagnation for all but the top 5%, including an unprecedented increase in death rate among US whites from diseases of dispair? [read post]
28 Aug 2019, 10:49 am
The nasal spray flu vaccine, sold under the name FluMist, is manufactured by AstraZeneca. [read post]
23 Aug 2019, 6:23 am by John Jascob
For an example of a bad interpretation of a complex contract that might have come out the right way with a little help of signals in the contract, take a look at Astex Therapeutics Limited and AstraZeneca AB, [2018] EWCA Civ. 2444, Case No. [read post]
21 Aug 2019, 4:00 am by Administrator
Astrazeneca Canada inc., 2019 QCCS 3323 [22] À cette étape, le tribunal exerce un rôle de filtrage. [read post]
5 Aug 2019, 12:27 am
Team NewsGuestKat Rose Hughes will soon begin a new role as Patent Attorney at AstraZeneca in Cambridge, UK.Africa Correspondent Chijioke Okorie has been appointed a Queen Elizabeth Scholar under the Open African Innovation Research (Open AIR) project. [read post]
20 May 2019, 9:13 am by Juvan Bonni
Michael Handler: Trademark Transactions in Common Law Countries: Liberalisation and Its Limits (Source: SSRN) New Job Postings on Patently-O: Ballard Spahr LLP–Part-Time Patent Associate or Agent MH2 Technology Law Group, LLP DiBerardino McGovern IP Group Ballard Spahr LLP–IP Attorney or Agent Saint Gobain North America Intellectual Property Owners Association The Kudelski Group Bejin Bieneman, PLC Caldwell Intellectual Property Law Dority & Manning AstraZeneca Shay Glenn… [read post]